Natesto™, a novel testosterone nasal gel, normalizes androgen levels in hypogonadal men

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Andrology

• Publication date

  2016-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/andr.12137PMID 26695758
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cardiovascular risks and elevation of serum DHT vary by route of testosterone administration: a systematic review and meta-analysis

  2014cited by this paper
• Male hypogonadism.

  2014cited by this paper
• Testosterone exposure in childhood: discerning pathology from physiology

  2013cited by this paper
• Identification of late-onset hypogonadism in middle-aged and elderly men.

  2010cited by this paper
• Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline.

  2010influential reference
• Testosterone gel monotherapy improves sexual function of hypogonadal men mainly through restoring erection: evaluation by IIEF score.

  2009cited by this paper
• Intranasal drug delivery: how, why and what for?

  2009cited by this paper
• Delivery of testosterone to the brain by intranasal administration: Comparison to intravenous testosterone

  2009cited by this paper
• Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial.

  2008cited by this paper
• Effect of Testosterone Supplementation on Functional Mobility, Cognition, and Other Parameters in Older Men: A Randomized Controlled Trial

  2008cited by this paper
• Testosterone supplementation for hypogonadal men by the nasal route

  2008influential reference
• Postmenopausal virilization after spousal use of topical androgens.

  2007cited by this paper
• ORIGINAL RESEARCH—ENDOCRINOLOGY: Subjective Sexual Response to Testosterone Replacement Therapy Based on Initial Serum Levels of Total Testosterone

  2007cited by this paper
• Testosterone use in men and its effects on bone health. A systematic review and meta-analysis of randomized placebo-controlled trials.

  2006cited by this paper
• Serum androgen levels in black, Hispanic, and white men.

  2006influential reference
• Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia.

  2004cited by this paper
• New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men.

  2004cited by this paper
• A comparison of a novel testosterone bioadhesive buccal system, striant, with a testosterone adhesive patch in hypogonadal males.

  2004cited by this paper
• AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function.

  2003cited by this paper
• AA 2500 Testosterone Gel Normalizes Androgen Levels in Aging Males with Improvements in Body Composition and Sexual Function

  2003cited by this paper
• The International Index of Erectile Function (IIEF): a state-of-the-science review

  2002influential reference
• Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men.

  2000cited by this paper
• Development and validation of brief measures of positive and negative affect: the PANAS scales.

  1988influential reference
• Male hypogonadism.

  1955cited by this paper

• Terapi Penggantian Testosterone pada Hipogonadisme Onset Lambat

  2026cites this paper
• Testosterone Replacement Therapy: Indications, Application Protocols, and Side Effect Profile

  2026cites this paper
• Late-onset hypogonadism: current methods of clinical diagnosis and treatment in Japan

  2025cites this paper
• Testosterone Therapy in Adult Males with Hypogonadism.

  2025cites this paper
• Investigating the effects of single-dose intranasal testosterone on economic preferences in a large randomized trial of men

  2025cites this paper
• Male hypogonadism: recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024).

  2025cites this paper
• Testosterone replacement therapy and spermatogenesis in reproductive age men

  2025cites this paper
• Testosterone Replacement, Where Are We in 2025?

  2025cites this paper
• Testosterone and Obesity in an Aging Society

  2025cites this paper
• Impact of electromagnetic field exposure on reproductive health: an umbrella review and meta-analysis of systematic reviews

  2025cites this paper
• Pharmacological management of testosterone deficiency in men current advances and future directions

  2024influential citation
• Efficacy and Safety of Testosterone Replacement in Testicular Cancer Survivors With Treatment-Influenced Hypogonadism: A Systematic Review

  2024cites this paper
• Testosterone replacement therapy in adolescents and young men

  2024cites this paper
• Gaps in evidence on treatment of male osteoporosis: a Research Agenda

  2023cites this paper
• Prevalence of secondary erythrocytosis in men receiving testosterone therapy: A matched-cohort analysis of intranasal gel, injections, and pellets.

  2023cites this paper
• Preserving spermatogenesis in testosterone deficiency: innovations in replacement and stimulatory therapies

  2023cites this paper
• Preparation of Tamsulosin Hydrochloride-Loaded Mucoadhesive In Situ Gelling Polymeric Formulation for Nasal Delivery in Geriatrics

  2023cites this paper
• Developments and challenges for new and emergent preparations for male hypogonadism treatment

  2023influential citation
• Intramuscularly injected long-acting testosterone-cholesterol prodrug suspension with three different particle sizes: extended in vitro release and enhanced in vivo safety

  2023cites this paper
• EMAS position statement: Testosterone replacement therapy in older men.

  2023cites this paper
• Comparison of Hematocrit Change in Testosterone-deficient Men Treated With Intranasal Testosterone Gel vs Intramuscular Testosterone Cypionate: A Randomized Clinical Trial

  2023cites this paper
• Testosterone therapy in children and adolescents: to whom, how, when?

  2022cites this paper
• Fertility Preservation in Hypogonadal Men

  2022cites this paper
• Long vs short acting testosterone treatments: A look at the risks.

  2022cites this paper
• Testosterone Replacement Options.

  2022cites this paper
• An Individualized Approach to Managing Testosterone Therapy in the Primary Care Setting

  2022cites this paper
• Testosterone Deficiency as One of the Major Endocrine Disorders in Chronic Kidney Disease

  2022cites this paper
• Novel androgen therapies including selective androgen receptor modulators.

  2022cites this paper
• Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors

  2022cites this paper
• Medical Treatment of Hypogonadism in Men.

  2022cites this paper
• Testosterone Replacement Therapy in Hypogonadal Men.

  2022cites this paper
• Testicular function

  2022cites this paper
• Practice-changing publications: Male infertility.

  2022cites this paper
• Testosterone therapy and secondary erythrocytosis

  2022cites this paper
• Herbal medicine use to treat andrological problems: Asian and Indian subcontinent: Ginkgo biloba, Curcuma longa, and Camellia sinensis

  2021cites this paper
• Testosterone and Bone Health in Men: A Narrative Review

  2021cites this paper
• An update on the available and emerging pharmacotherapy for adults with testosterone deficiency available in the USA

  2021cites this paper
• Advances in stem cell research for the treatment of primary hypogonadism

  2021cites this paper
• Medical therapies causing iatrogenic male infertility.

  2021cites this paper
• Strategies for the delivery of antidiabetic drugs via intranasal route.

  2021cites this paper
• Pharmacokinetics of testosterone therapies in relation to diurnal variation of serum testosterone levels as men age

  2021cites this paper
• Updated protocols for optimizing sperm recovery after steroid use

  2021cites this paper
• Hypogonadism in Male Infants and Adolescents: New Androgen Formulations

  2021cites this paper
• Converting men from Clomiphene Citrate to Natesto for hypogonadism improves libido, maintains semen parameters, and reduces estradiol.

  2020cites this paper
• Intranasal 17β-Estradiol Modulates Spatial Learning and Memory in a Rat Model of Surgical Menopause

  2020cites this paper
• Strategies to Increase Testosterone in Men Seeking Fertility

  2020cites this paper
• Short-Acting Testosterone: More Physiologic?

  2020cites this paper
• The Effect of Longer-Acting vs Shorter-Acting Testosterone Therapy on Follicle Stimulating Hormone and Luteinizing Hormone.

  2020cites this paper
• A cross-sectional comparison of secondary polycythemia in testosterone-deficient men treated with nasal testosterone gel vs. intramuscular testosterone cypionate.

  2020cites this paper
• Understanding the Complex Relationship Between Androgens and SARS-CoV2

  2020cites this paper
• Editorial Comment.

  2020cites this paper
• Nasal Testosterone in Testosterone Deficiency: Is It a Paradigm Shift Yet?

  2020cites this paper
• Short-acting testosterone appears to have lesser effect on male reproductive potential compared to long-acting testosterone in mice.

  2020cites this paper
• Effect of Natesto on Reproductive Hormones, Semen Parameters and Hypogonadal Symptoms: A Single-Center, Open-Label, Single-Arm Trial.

  2020cites this paper
• Testosterone Therapy in Male Infertility

  2020cites this paper
• Treatment of Adult Male Hormonal Disorders

  2020cites this paper
• New frontiers in fertility preservation: a hypothesis on fertility optimization in men with hypergonadotrophic hypogonadism

  2020cites this paper
• Testosterone replacement therapy

  2020cites this paper
• Testosterone Use in Adolescent Males: Current Practice and Unmet Needs

  2020cites this paper
• Exogenous testosterone replacement therapy versus raising endogenous testosterone levels: current and future prospects.

  2020cites this paper
• The My-T study: Patient satisfaction and preference comparing topical and nasal testosterone therapies.

  2019cites this paper
• Paediatric and adult-onset male hypogonadism

  2019cites this paper
• Current Hypogonadism Treatment Options

  2019cites this paper
• Title: Does testosterone impair men’s cognitive empathy? Evidence from two large-scale randomized controlled trials Short title/running head: Does testosterone impair men’s cognitive empathy?

  2019cites this paper
• ENDOCRINE HISTORY: The history of discovery, synthesis and development of testosterone for clinical use.

  2019cites this paper
• Does testosterone impair men’s cognitive empathy? Evidence from two large-scale randomized controlled trials

  2019cites this paper
• MY-T study: Symptom-based titration decisions when using testosterone nasal gel, Natesto®.

  2019cites this paper
• Testosterone Therapy in Adolescent Boys: The Need for a Structured Approach

  2019cites this paper
• Testosterone and Men's Health

  2019cites this paper
• Efficacy of Nasal Testosterone Gel (Natesto®) Stratified by Baseline Endogenous Testosterone Levels

  2019cites this paper
• Natesto Effects on Reproductive Hormones and Semen Parameters: Results from an Ongoing Single-center, Investigator-initiated Phase IV Clinical Trial.

  2018cites this paper
• Novel Therapy for Male Hypogonadism

  2018cites this paper
• Statistical Design of Experiment (DoE) based development and optimization of DB213 in situ thermosensitive gel for intranasal delivery.

  2018cites this paper
• Effect of exogenous testosterone on cooperation depends on personality and time pressure

  2018cites this paper
• Testosterone Is a Contraceptive and Should Not Be Used in Men Who Desire Fertility

  2018cites this paper
• Phase 1 pharmacokinetics and phase 3 efficacy of testosterone nasal gel in subjects with seasonal allergies.

  2018cites this paper
• Nasal drug absorption from powder formulations: The effect of three types of hydroxypropyl cellulose (HPC)

  2017cites this paper
• Treatment of Hypogonadism: Current and Future Therapies

  2017cites this paper
• Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels

  2017cites this paper
• Testosterone Therapy: Transdermal Androgens

  2017cites this paper
• Intranasal delivery of Natesto® testosterone gel and its effects on doping markers.

  2016influential citation
• Emerging medication for the treatment of male hypogonadism

  2016cites this paper